• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Turkey Pharmaceuticals and Healthcare Report Q4 2010 Product Image

Turkey Pharmaceuticals and Healthcare Report Q4 2010

  • Published: August 2010
  • Region: Turkey
  • 75 Pages +
  • Business Monitor International

FEATURED COMPANIES

  • Abdi Ibrahim
  • Bayer
  • Fako (Actavis)
  • Merck & Co
  • Pfizer
  • Sanofi-Aventis
  • MORE

The Turkey Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Turkey's pharmaceuticals and healthcare industry.

This report outlook for pharmaceutical companies operating in the Emerging Europe region has improved further over the past quarter, as shown by our updated Pharmaceuticals and Healthcare Business Environment Ratings (BERs) matrix. However, while Turkey’s compound quarterly score has improved somewhat, its regional ranking has actually worsened to sixth (from fourth), overtaken by Russia and Hungary. Globally, Turkey remains 26th of the 83 pharmaceutical markets surveyed by BMI. While a number of major multinationals have indicated that Turkey is of major interest to them as a key emerging market, the recent pricing and reimbursement reforms will continue to weigh on the growth of market values, as will shortcomings in its intellectual property (IP) environment.

In fact, during the most recent European Union (EU)-Turkey Association Council's meeting, the EU backed Turkey's READ MORE >

Executive Summary

SWOT Analysis
Turkey Pharmaceuticals And Healthcare Industry SWOT
Turkey Political SWOT
Turkey Economic SWOT
Turkey Business Environment SWOT

Pharmaceutical Business Environment Ratings
Table: Central And Eastern Europe Pharmaceutical Business Environment Ratings, Q410
Rewards
Risks

Turkey - Market Summary

Regulatory Regime
Intellectual Property Regime
Intellectual Property Shortcomings
Counterfeit Drugs

Recent Developments Regarding Counterfeit Drugs
Pricing Regime
Table: Turkish Pharmacy & Wholesale Mark-Ups
Reimbursement Regime

Industry Developments
Epidemiology
Table: Disease Burden In Emerging Europe
Non-Communicable Diseases
Communicable Diseases
Healthcare Sector
Healthcare Expenditure
Healthcare Sector Reforms
Health Insurance
Private Healthcare Sector
Medical Tourism
International Cooperation
Research & Development Sector
Table: Turkey’s 2008 R&D Law
Clinical Trials Industry
Medical Devices Industry

Industry Forecast Scenario
Overall Market Forecast
Key Growth Factors – Industry
Key Growth Factors – Macroeconomic
Table: Turkey – Economic Activity
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Medical Device Market Forecast
Pharmaceutical Trade Forecast
Other Healthcare Data
Key Risks to Forecasts

Competitive Landscape
Pharmaceutical Sector
Table: Top 10 Pharmaceutical Companies In Turkey By Market Share, MAT July 2008
Domestic Industry
Foreign Industry

Recent Pharmaceutical Sector Developments
Pharmaceutical Retail And Distribution

Company Profiles
Indigenous Companies
Abdi Ibrahim
Eczacibasi Pharmaceuticals
Sanovel Pharmaceuticals
EastPharma (formerly Deva)
Fako (Actavis)
Biomeks
Multinational Companies
Novartis
Sanofi-Aventis
GlaxoSmithKline
Pfizer
Roche
AstraZeneca
Bayer
Merck & Co

Country Snapshot: Turkey Demographic Data
Section 1: Population
Table: Demographic Indicators, 2005-2030
Table: Rural/Urban Breakdown, 2005-2030
Section 2: Education And Healthcare
Table: Education, 2002-2005
Table: Vital Statistics, 2005-2030
Section 3: Labour Market And Spending Power
Table: Employment Indicators, 2001-2006
Table: Consumer Expenditure, 2000-2012 (US$)

BMI Methodology
How We Generate Our Pharmaceutical Industry Forecasts
Risk/Reward Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources

Forecast Tables

- Abdi Ibrahim

- Eczacibasi Pharmaceuticals

- Sanovel Pharmaceuticals

- EastPharma (formerly Deva)

- Fako (Actavis)

- Biomeks

- Novartis

- Sanofi-Aventis

- GlaxoSmithKline

- Pfizer

- Roche

- AstraZeneca

- Bayer

- Merck & Co

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS

Our Clients

Our clients' logos